Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multitargeting nature of muscarinic orthosteric agonists and antagonists. | Front Physiol | 2022 | 36148314 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Immune Landscape Based on Tumor Microenvironment for Oral Squamous Cell Carcinoma Prognosis. | Vaccines (Basel) | 2022 | 36146599 | PubTator, text mining | PubMed |
| Distinct sex-specific DNA methylation differences in Alzheimer's disease. | Alzheimers Res Ther | 2022 | 36109771 | PubTator, text mining | PubMed |
| Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods. | Medicine (Baltimore) | 2022 | 36107502 | PubTator, text mining | PubMed |
| Calculation of exact Shapley values for support vector machines with Tanimoto kernel enables model interpretation. | iScience | 2022 | 36105596 | PubTator, text mining | PubMed |
| A Selective Adenosine A3 Receptor Antagonist, HL3501, Has Therapeutic Potential in Preclinical Liver and Renal Fibrosis Models. | In Vivo | 2022 | 36099145 | PubTator, text mining | PubMed |
| Integrative and comparative single-cell analysis reveals transcriptomic difference between human tumefactive demyelinating lesion and glioma. | Commun Biol | 2022 | 36085357 | PubTator, text mining | PubMed |
| Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications. | Expert Opin Ther Targets | 2022 | 36069761 | PubTator, text mining | PubMed |
| The low affinity A2B adenosine receptor enhances migratory and invasive capacity in vitro and angiogenesis in vivo of glioblastoma stem-like cells. | Front Oncol | 2022 | 36059665 | PubTator, text mining | PubMed |
| Identification of early biomarkers of transcriptomics in alveolar macrophage for the prognosis of intubated ARDS patients. | BMC Pulm Med | 2022 | 36056346 | PubTator, text mining | PubMed |
| Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19. | Front Pharmacol | 2022 | 36052135 | PubTator, text mining | PubMed |
| Expression profiles of exosomal tRNA-derived fragments and their biological functions in lipomas. | Front Cell Dev Biol | 2022 | 36035989 | PubTator, text mining | PubMed |
| Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis. | Pharmaceuticals (Basel) | 2022 | 36015085 | PubTator, text mining | PubMed |
| Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy. | Int J Mol Sci | 2022 | 36012771 | PubTator, text mining | PubMed |
| A2B Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New Insights into MRP3 Transporter Function. | Int J Mol Sci | 2022 | 36012307 | PubTator, text mining | PubMed |
| The Hypoxia-Adenosine Link during Myocardial Ischemia-Reperfusion Injury. | Biomedicines | 2022 | 36009485 | PubTator, text mining | PubMed |
| Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis. | Diab Vasc Dis Res | 2022 | 35989592 | PubTator, text mining | PubMed |
| Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma. | Comput Math Methods Med | 2022 | 35983531 | PubTator, text mining | PubMed |
| Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gαi3 and GαoA Isoprotein Activation. | ACS Pharmacol Transl Sci | 2022 | 35983277 | PubTator, text mining | PubMed |
| GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A2A Adenosine Receptor. | J Med Chem | 2022 | 35977382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=14